Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis

European Journal of Preventive Cardiology

Volumn 24, Issue 14, 2017, Pages 1555-1566

  Ruddox, Vidar ^a   Sandven, Irene ^b   Munkhaugen, John ^c   Skattebu, Julie ^a   Edvardsen, Thor ^b   Otterstad, Jan Erik ^a  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Drammen Hospital Trust   (Norway)

Author keywords

Atrial fibrillation; heart failure; mortality; myocardial infarction

Indexed keywords

ALL CAUSE MORTALITY; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; AGED; CAUSE OF DEATH; CORONARY ARTERY DISEASE; FEMALE; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; TIME FACTOR;

AGED; ATRIAL FIBRILLATION; CAUSE OF DEATH; CORONARY DISEASE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 85029332869     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487317715769     Document Type: Review

References (35)

1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2016; 37: 2893-2962.
2. EHRA Scientific Committee Task Force, Gorenek B, Pelliccia A, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace: European pacing, arrhythmias, and cardiac electrophysiology: Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2017; 19: 190-225. DOI: 10.1093/europace/euw242.
3. Vermond RA, Van Gelder IC, Crijns HJ, et al. Does myocardial infarction beget atrial fibrillation and atrial fibrillation beget myocardial infarction? Circulation 2015; 131: 1824-1826.
4. Gomez-Outes A, Lagunar-Ruiz J, Terleira-Fernandez AI, et al. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2016; 68: 2508-2521.
5. Soliman EZ, Lopez F, O'Neal WT, et al. Atrial fibrillation and risk of ST-segment elevation versus non-ST-segment elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2015; 131: 1843-1850.
6. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012.
7. Aune E, Endresen K, Fox KA, et al. Effect of implementing routine early invasive strategy on one-year mortality in patients with acute myocardial infarction. Am J Cardiol 2010; 105: 36-42.
8. Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-1045.
9. Kaw R, Hernandez AV, Masood I, et al. Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2011; 141: 1305-1312.
10. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality in non-randomized studies in meta-analysis. Ottawa, Canada: Ottawa Health Research Institute, 1999. www.ohri.ca/programs/clinical-epidemiology/oxford.asp (accessed 29 May 2014).
11. Ruigomez A, Johansson S, Wallander MA, et al. Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis. Int J Cardiol 2009; 136: 186-192.
12. Marte T, Saely CH, Schmid F, et al. Effectiveness of atrial fibrillation as an independent predictor of death and coronary events in patients having coronary angiography. Am J Cardiol 2009; 103: 36-40.
13. Vermond RA, Geelhoed B, Verweij N, et al. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. J Am Coll Cardiol 2015; 66: 1000-1007.
14. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
16. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-1379.
17. Viechtbauer W, Cheung MW,. Outlier and influence diagnostics for meta-analysis. Res Synth Methods 2010; 1: 112-125.
18. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002-d4002.
19. Rohla M, Vennekate CK, Tentzeris I, et al. Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. Int J Cardiol 2015; 184: 108-114.
20. O'Neal WT, Sangal K, Zhang ZM, et al. Atrial fibrillation and incident myocardial infarction in the elderly. Clin Cardiol 2014; 37: 750-755.
21. Chao TF, Huang YC, Liu CJ, et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm 2014; 11: 1941-1947.
22. Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Int Med 2014; 174: 107-114.
23. Bramlage P, Cuneo A, Zeymer U, et al. Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents. Clin Res Cardiol: Official journal of the German Cardiac Society 2013; 102: 289-297.
24. Conen D, Chae CU, Glynn RJ, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA: The journal of the American Medical Association 2011; 305: 2080-2087.
25. Jabre P, Jouven X, Adnet F, et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation 2011; 123: 2094-2100.
26. Goto S, Bhatt DL, Rother J, et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008; 156: 855-863. 863, e852.
27. Otterstad JE, Kirwan BA, Lubsen J, et al. Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease. Scand Cardiovasc J: SCJ 2006; 40: 152-159.
28. Bouzas-Mosquera A, Peteiro J, Broullon FJ, et al. Effect of atrial fibrillation on outcome in patients with known or suspected coronary artery disease referred for exercise stress testing. Am J Cardiol 2010; 105: 1207-1211.
29. Andersson T, Magnuson A, Bryngelsson IL, et al. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol 2014; 177: 91-99.
30. Odutayo A, Wong CX, Hsiao AJ, et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016; 354: i4482-i4482.
31. Guo XY, Li N, Du X, et al. Atrial fibrillation is associated with an increased risk of myocardial infarction: insights from a meta-analysis. Atherosclerosis 2016; 254: 1-7.
32. Hobbs FR, Taylor CJ, Jan Geersing G, et al. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. Eur J Prev Cardiol 2016; 23: 460-473.
33. Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 2016; 532: h7013-h7013.
34. Bayturan O, Puri R, Tuzcu EM, et al. Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction. Eur J Prev Cardiol 2017; 24: 373-381.
35. Wijesurendra RS, Liu A, Eichhorn C, et al. Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation. Circulation 2016; 134: 1068-1081.